Madrid, Spain

Luis Paz-Ares Rodríguez

This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Fundacion De Investigacion Hospital 12 De Octubre, Fundación Del Sector Público Estatal Centro Nacional De Investigaciones Oncologicas Carlos III (f.s.p. Cnio), Fundación Para La Investigación Biomédica Del Hospital Universitario 12 De Octubre. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luis Paz-Ares Rodríguez. Retrieved from https://idiyas.com/inventor/luis-paz-ares-rodriguez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.8

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Luis Paz-Ares Rodriguez

Introduction

Luis Paz-Ares Rodriguez is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of biomedical research, particularly in the detection of minimal residual disease (MRD) in patients who have undergone treatment for proliferative diseases. His work has the potential to improve patient outcomes and enhance the understanding of disease recurrence.

Latest Patents

Luis Paz-Ares Rodriguez holds a patent for a "Method for determining the presence or absence of minimal residual disease (MRD) in a subject who has been treated for a disease." This invention focuses on a method, kit, and system designed to accurately determine the presence or absence of MRD, which is crucial for monitoring patients post-treatment.

Career Highlights

Throughout his career, Luis has worked with esteemed organizations such as the Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre and the Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III. His experience in these institutions has allowed him to contribute to significant advancements in cancer research and treatment methodologies.

Collaborations

Luis has collaborated with notable colleagues in his field, including Santiago Barrio García and Rosa María Ayala Díaz. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Luis Paz-Ares Rodriguez is a distinguished inventor whose work in the detection of minimal residual disease has the potential to transform patient care in oncology. His contributions to biomedical research highlight the importance of innovation in improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…